Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

New Eli Lilly Drug Retatrutide Brought Major Weight Loss in Trial

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.

Gina Kolata
Author: Gina Kolata

Written by

Gina Kolata

in

Clinical Trials, Eli Lilly and Company, GLP-1 RAs (Drug), Knees, Obesity, Research, Retatrutide
←Watch Lauren Boebert Haggle With Bouncer At George Santos’ Christmas Party
Why Oracle Is Worrying Investors About the A.I. Boom→

More posts

  • Protesters, leaders push back against DHS over Newark detention facility conditions

  • Goldman and Lander spar hard over Israel

  • Snowflake climbs after Q1 results top expectations, guidance gets a boost

  • Synopsys drops despite better than expected Q2 results, big boost to full-year guidance

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube